KR930006006A - 치환된 피리디닐아미노-1H-인돌, 1H-인다졸, 2H-인디졸, 벤조[b]티오펜 및 1,2-벤즈이소티아졸, 이들의 제조방법 및 약제로서의 이들의 용도 - Google Patents

치환된 피리디닐아미노-1H-인돌, 1H-인다졸, 2H-인디졸, 벤조[b]티오펜 및 1,2-벤즈이소티아졸, 이들의 제조방법 및 약제로서의 이들의 용도 Download PDF

Info

Publication number
KR930006006A
KR930006006A KR1019920017238A KR920017238A KR930006006A KR 930006006 A KR930006006 A KR 930006006A KR 1019920017238 A KR1019920017238 A KR 1019920017238A KR 920017238 A KR920017238 A KR 920017238A KR 930006006 A KR930006006 A KR 930006006A
Authority
KR
South Korea
Prior art keywords
lower alkyl
compound
hydrogen
aryl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019920017238A
Other languages
English (en)
Korean (ko)
Inventor
차알스 에폴란드 리차드
토마스 클라인 조지프
엘. 마틴 로렌스
Original Assignee
제롬 로센스톡
훽스트-럿셀 파마슈티칼즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제롬 로센스톡, 훽스트-럿셀 파마슈티칼즈 인코포레이티드 filed Critical 제롬 로센스톡
Publication of KR930006006A publication Critical patent/KR930006006A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019920017238A 1991-09-23 1992-09-22 치환된 피리디닐아미노-1H-인돌, 1H-인다졸, 2H-인디졸, 벤조[b]티오펜 및 1,2-벤즈이소티아졸, 이들의 제조방법 및 약제로서의 이들의 용도 Withdrawn KR930006006A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/764,031 US5185350A (en) 1991-09-23 1991-09-23 Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US07/764,031 1991-09-23

Publications (1)

Publication Number Publication Date
KR930006006A true KR930006006A (ko) 1993-04-20

Family

ID=25069502

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920017238A Withdrawn KR930006006A (ko) 1991-09-23 1992-09-22 치환된 피리디닐아미노-1H-인돌, 1H-인다졸, 2H-인디졸, 벤조[b]티오펜 및 1,2-벤즈이소티아졸, 이들의 제조방법 및 약제로서의 이들의 용도

Country Status (18)

Country Link
US (2) US5185350A (enExample)
EP (1) EP0534343B1 (enExample)
JP (1) JP2961023B2 (enExample)
KR (1) KR930006006A (enExample)
AT (1) ATE160346T1 (enExample)
AU (1) AU653263B2 (enExample)
CA (1) CA2078814C (enExample)
CZ (1) CZ290692A3 (enExample)
DE (1) DE69223205T2 (enExample)
DK (1) DK0534343T3 (enExample)
ES (1) ES2111025T3 (enExample)
FI (1) FI924230L (enExample)
GR (1) GR3025774T3 (enExample)
HU (1) HU9203023D0 (enExample)
IL (1) IL103232A0 (enExample)
MX (1) MX9205374A (enExample)
NO (1) NO923686L (enExample)
TW (1) TW207539B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230027814A (ko) * 2021-08-20 2023-02-28 김수영 포켓 인슐레이터 및 이를 포함하는 단열체

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550507A1 (en) * 1990-09-13 1993-07-14 Beecham Group p.l.c. Indole ureas as 5 ht receptor antagonist
US5356910A (en) 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
EP0735821A4 (en) * 1993-12-21 1998-04-01 Lilly Co Eli METHODS FOR TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH AMYLO DOGEN PEPTIDES
DE19626373A1 (de) * 1996-07-02 1998-01-08 Boehringer Ingelheim Kg Neuartige Verwendung von Wirkstoffen, welche die Funktion von nichtneuronalem Acetylcholin beeinflussen
TW200302722A (en) * 2002-02-13 2003-08-16 Astrazeneca Ab Therapeutic agents
US20050222123A1 (en) 2004-01-27 2005-10-06 North Shore-Long Island Jewish Research Institute Cholinesterase inhibitors for treating inflammation
JP4857128B2 (ja) 2004-02-20 2012-01-18 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規な化合物
JP4787471B2 (ja) * 2004-05-21 2011-10-05 株式会社ポッカコーポレーション 脳機能亢進剤
BRPI0511722A (pt) 2004-06-01 2008-01-08 Hoffmann La Roche 3-amino-1-arilpropilindóis como inibidores da recaptação de monoamina
EP1957488B1 (en) 2005-11-30 2009-09-09 F.Hoffmann-La Roche Ag 3-amino-2-arylpropyl azaindoles and uses thereof
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
RU2008120138A (ru) * 2005-11-30 2010-01-10 Ф. Хоффманн-Ля Рош Аг (Ch) 3-амино-1-арилпропилиндолы и аза-замещенные индолы

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065324T3 (es) * 1987-04-24 1995-02-16 Hoechst Roussel Pharma N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
US4970219A (en) * 1989-06-28 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which have useful utility in treating skin disorders
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230027814A (ko) * 2021-08-20 2023-02-28 김수영 포켓 인슐레이터 및 이를 포함하는 단열체

Also Published As

Publication number Publication date
NO923686D0 (no) 1992-09-22
MX9205374A (es) 1993-03-01
ATE160346T1 (de) 1997-12-15
IL103232A0 (en) 1993-02-21
CZ290692A3 (en) 1993-04-14
FI924230A7 (fi) 1993-03-24
US5328918A (en) 1994-07-12
DK0534343T3 (da) 1998-07-27
HUT64055A (en) 1993-11-29
ES2111025T3 (es) 1998-03-01
DE69223205D1 (de) 1998-01-02
JP2961023B2 (ja) 1999-10-12
CA2078814A1 (en) 1993-03-24
AU653263B2 (en) 1994-09-22
US5185350A (en) 1993-02-09
TW207539B (enExample) 1993-06-11
EP0534343A1 (en) 1993-03-31
NO923686L (no) 1993-03-24
FI924230L (fi) 1993-03-24
HU9203023D0 (en) 1993-11-29
AU2529792A (en) 1993-03-25
JPH061787A (ja) 1994-01-11
FI924230A0 (fi) 1992-09-21
EP0534343B1 (en) 1997-11-19
DE69223205T2 (de) 1998-05-14
CA2078814C (en) 2003-09-09
GR3025774T3 (en) 1998-03-31

Similar Documents

Publication Publication Date Title
KR920002596A (ko) 아지비사이클로 유도체
KR930006006A (ko) 치환된 피리디닐아미노-1H-인돌, 1H-인다졸, 2H-인디졸, 벤조[b]티오펜 및 1,2-벤즈이소티아졸, 이들의 제조방법 및 약제로서의 이들의 용도
KR920006314A (ko) 아릴알킬아민, 이의 제조방법 및 이를 함유하는 약제학적 조성물
DE69426331D1 (de) Arzneimittel gegen nervöse erkrankungen
KR930019655A (ko) 종양치료 조성물 및 치료방법
MA26727A1 (fr) Derives nouveaux de pyrimidine inhibiteurs de sorbitol deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant
KR890016966A (ko) 신규 항바이러스제
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
KR870010067A (ko) 신규의 디포스폰산 화합물, 이들의 제조 방법 및 이들을 함유하는 제약조성물
FR2684103B1 (fr) Nouveaux composes a structure guanidique et composition pharmaceutique les contenant.
RU94046141A (ru) Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция
KR890006228A (ko) 항종양제로서 폴리아민 유도체
KR890005036A (ko) 아미드화합물, 이들의 제조방법 및 이들 화합물을 함유하여 위신경기능을 활성화하는 조성물
KR890000428A (ko) 신규의 2-피라졸린 유도체 및 이를 주성분으로 하는 뇌혈관 장애치료제
KR950032171A (ko) 옥소피리디닐퀴녹살린 유도체
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
KR900011724A (ko) 특정 피롤릴페닐-치환된 하이드록삼산 유도체
KR950703341A (ko) 항부정맥제
DE60124117D1 (de) Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms
ATE263183T1 (de) A-500359-derivate
KR870006035A (ko) 신규 항균제 1-티에닐-4-옥소퀴놀린-3-카복실산 화합물의 제법
KR960702458A (ko) 퀴놀린 유도체 또는 그의 염 및 이를 함유 하는 항균제
KR950703955A (ko) 테르피리딘 유도체의 약학적 용도
KR890009862A (ko) N-치환 메르캅토 프로판아미드 유도체
KR910016692A (ko) 신규 8-술파밀메틸렌-2-아미노 테트랄린

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19920922

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid